Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyra Therapeutics

11.85
-1.6500-12.22%
Pre-market: 11.79-0.0600-0.51%08:33 EDT
Volume:370.19K
Turnover:4.51M
Market Cap:15.71M
PE:-0.20
High:13.50
Open:13.33
Low:11.51
Close:13.50
Loading ...

Lyra Therapeutics trading halted, news pending

TIPRANKS
·
28 May

US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert

Benzinga
·
20 May

Lyra Therapeutics Announces Reverse Stock Split Decision

TIPRANKS
·
20 May

Lyra Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
20 May

Lyra Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Lyra Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
07 May

Lyra Therapeutics Q1 EPS $(0.13) Beats $(0.15) Estimate, Sales $183.00K Miss $240.00K Estimate

Benzinga
·
07 May

Lyra Therapeutics Q1 EPS USD -0.13

THOMSON REUTERS
·
07 May

Lyra Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
25 Apr

Lyra Therapeutics Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), aTyr Pharma (ATYR) and Lyra Therapeutics (LYRA)

TIPRANKS
·
14 Mar

Lyra Therapeutics FY 2024 GAAP EPS $(1.43) Misses $(1.38) Estimate, Sales $1.534M Beat $1.524M Estimate

Benzinga
·
14 Mar

Press Release: Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
14 Mar

Lyra Therapeutics Pursues ENLIGHTEN 2 Trial for LYR-210

TIPRANKS
·
11 Jan

Lyra Therapeutics (LYRA) Upgraded to Strong Buy: Here's What You Should Know

Zacks
·
10 Jan

Lyra Therapeutics Restructures Board of Directors

TIPRANKS
·
14 Dec 2024